O

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Director – Commercial Insights and Analytics

Product MarketingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree is required; an MBA, PhD, or another relevant advanced degree is preferred.
  • Strong understanding of biopharmaceutical commercialization in oncology markets, including patient journeys, customer behavior, treatment dynamics, market access, and launch performance.
  • Deep expertise in analytical methodologies sufficient to frame business questions, interpret outputs, challenge assumptions, and partner effectively with technical and analytical colleagues.
  • At least 10 years of progressive responsibility in biopharmaceutical market research, insights, forecasting, competitive intelligence, commercial strategy, management consulting, or related disciplines.
  • Use a forward-looking approach to insights generation, including AI-enabled tools, automation, and other modern research methodologies to increase the speed, scale, and quality of market research and strategic insights.
  • Track record of successfully supporting late-stage assets, launch planning, and in-market brands.
  • Strong capability in patient-based commercial forecasting, scenario analysis, and market assessment.
  • Proven ability to integrate primary research, competitive intelligence, secondary analyses, epidemiology, and other evidence into a coherent strategic perspective.
  • Ability to present recommendations and influence decisions with senior executives and cross-functional leadership teams.
  • Experience successfully managing agencies, consultants, and other external partners.
  • Collaborate effectively across disciplines and develop strong partnerships across Commercial, Analytics, Data Science, Market Access, Medical Affairs, Clinical Development, Finance, and other functions.
  • Work effectively in a fast-moving environment where information is incomplete and priorities evolve.
  • Bring rigor, objectivity, sound judgment, and appropriate challenge to strategic decision-making.

Responsibilities

  • Serve as the lead insights thought partner to Commercial leadership, identifying the critical questions, risks, and opportunities that should inform strategy and execution.
  • Lead an integrated insights planning process and synthesize primary research, secondary data, competitive intelligence, epidemiology, and market developments into a cohesive market perspective.
  • Translate insights into clear implications and recommendations, identifying priority knowledge gaps and the appropriate approach to address them.
  • Own the primary market research strategy and annual research plan supporting Olema’s portfolio and commercialization priorities.
  • Design and execute qualitative and quantitative research to generate insights into unmet needs, treatment decisions, product perceptions, adoption barriers, and market opportunities.
  • Lead the development, refinement, and governance of patient-based commercial forecasts for Olema’s late-stage portfolio, incorporating epidemiology, patient flow, market research, competitive dynamics, access assumptions, analogs, and clinical and regulatory events.
  • Develop and communicate scenario-based forecasts to support long-range planning, portfolio prioritization, lifecycle strategy, and business development assessments.
  • Lead commercial competitive intelligence for Olema’s priority disease areas, maintaining an integrated view of competitors, emerging mechanisms, and evolving treatment paradigms.
  • Lead synthesis around major congresses, data readouts, regulatory events, and other high-impact milestones.
  • Define the strategic measurement framework for launch, including KPIs and leading indicators spanning patient dynamics, customer engagement, access, adoption, and market evolution.
  • Partner with analytical colleagues to ensure required data, reporting, and measurement capabilities are in place.
  • Lead interpretation of launch performance, integrating quantitative signals with primary research, field insights, and competitive context to identify drivers and recommended actions.

Desired Qualifications

  • An MBA, PhD, or another relevant advanced degree is preferred.

About the Company

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Olema Oncology develops targeted therapies for women’s cancers, with a focus on ER-positive, HER2-negative breast cancer. Its lead drug, palazestrant (OP-1250), blocks and degrades the estrogen receptor (CERAN/SERD) to slow tumor growth, and a second program targets epigenetics with a KAT6 inhibitor in preclinical stages. The company is conducting a Phase 3 trial of palazestrant in combination with CDK4/6 inhibitors and has a collaboration with Novartis to test palazestrant with ribociclib and everolimus. Its goal is to bring palazestrant to market and advance the KAT6 program to clinical testing, expanding options for women with breast cancer.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Olema Oncology

See more jobs